Dysfunctional RVOT Conduit clinical trials at UCLA
1 research study open to eligible people
Showing trials for
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
open to all eligible people
This study will demonstrate the safety and effectiveness of the Edwards Lifesciences SAPIEN 3/SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve (THV) Systems in subjects with a dysfunctional right ventricular outflow tract (RVOT) conduit or previously implanted valve in the pulmonic position with a clinical indication for intervention.
Los Angeles, California and other locations
Our lead scientists for Dysfunctional RVOT Conduit research studies include Jamil Aboulhosn.
Last updated: